Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Protein β-O-glucosylation by Legionella LtpM through short consensus sequons G-T/S and S-G.

Nature chemical biology·2025
Same author

Mutant glycosidases for labeling sialoglycans with high specificity and affinity.

Nature communications·2025
Same author

Fast Metabolic Glycan Labeling for Click-Labeling and Imaging of Sialoglycans in Living Acute Brain Slices from Mice and Human Patients.

Journal of the American Chemical Society·2024
Same author

Proximitomics by Reactive Species.

ACS central science·2024
Same author

Perioperative and post-hospital whole-course nutrition management in patients with pancreatoduodenectomy - a single-center prospective randomized controlled trial.

International journal of surgery (London, England)·2024
Same author

Blood-Brain Barrier Penetrating Nanovehicles for Interfering with Mitochondrial Electron Flow in Glioblastoma.

ACS nano·2024

相关实验视频

Updated: Sep 10, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

431

用针对癌细胞的抗体进行增强瘤免疫治疗的γδT细胞的化学工程

Long Chen1, Bo Cheng2,3,4, Zhanqun Yang1

  • 1Department of Pharmacy, Peking University Third Hospital Cancer Center, Peking University Third Hospital, Beijing 100191, China.

National science review
|August 22, 2025
PubMed
概括

工程造型的马三角T细胞更有效地向瘤. 抗体结合增强了它们杀死癌症的能力,并重塑了瘤微环境以获得更好的免疫反应.

关键词:
抗体-γδ T 细胞结合物化学工程代谢性甘氨酸标签酸的使用瘤微环境

更多相关视频

Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product
11:51

Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product

Published on: September 22, 2021

9.2K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791

相关实验视频

Last Updated: Sep 10, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

431
Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product
11:51

Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product

Published on: September 22, 2021

9.2K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791

科学领域:

  • 免疫学
  • 生物技术
  • 癌症治疗

背景情况:

  • 玛三角形 (γδ) T 细胞具有治疗潜力,但瘤向性有限.
  • 目前的策略在增强对瘤的γδT细胞疗效方面面临挑战.

研究的目的:

  • 为改善瘤向和采用细胞治疗开发抗体-γδ T 细胞结合物.
  • 通过代谢甘氨酸标记和点击化学来改进癌症治疗的 γδ T 细胞.

主要方法:

  • 使用代谢甘氨酸标记以通过酸将抗体固定在 γδ T 细胞上.
  • 采用点击化学,将编程死亡配体1 (PD-L1) 特定的纳米体 (αPD-L1) 结合到 γδ T 细胞上.
  • 评估了αPD-L1-γδ T细胞对各种癌症模型的疗效,包括细胞系,原始细胞和异种移植.

主要成果:

  • αPD- L1- γδ T细胞对PD- L1- 阳性癌细胞和瘤有增强的细胞毒性.
  • 改造的 γδ T 细胞诱导了癌细胞灭并重塑了瘤的微环境.
  • 通过CCR5/CCL5轴观察到CD8+T细胞的招募和激活,表明免疫活性瘤微环境.

结论:

  • 通过代谢甘氨酸标记的抗体结合为工程 γδ T 细胞提供了一种多功能策略.
  • 这种方法显著改善了γδT细胞介导的瘤向和治疗效果.
  • 工程化的 γδ T 细胞有望在癌症治疗中推进采用细胞治疗.